美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 203433 001 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.1MG/INH;EQ 0.05MG BASE/INH No No 2020/12/17 2020/12/17 HIKMA Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 203433 002 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.25MG/INH;EQ 0.05MG BASE/INH No No 2020/12/17 2020/12/17 HIKMA Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 203433 003 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.5MG/INH;EQ 0.05MG BASE/INH No No 2020/12/17 2023/12/19 HIKMA Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 213948 001 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.1MG/INH;EQ 0.05MG BASE/INH No No 2021/12/13 2021/12/13 TEVA PHARMS USA Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 213948 002 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.25MG/INH;EQ 0.05MG BASE/INH No No 2021/12/13 2021/12/13 TEVA PHARMS USA Prescription
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 213948 003 ANDA FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE POWDER;INHALATION 0.5MG/INH;EQ 0.05MG BASE/INH No No 2021/12/13 2021/12/13 TEVA PHARMS USA Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database